Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gonadorelin 100microgram pdr & solv inj vials
0605010P0AAAAAA
|
Gonadorelin | Gonadorelin | Endocrine System | No data available |
|
Gonal-f 1,050unit inj vials
0605010I0BBAFAF
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 150unit inj ampoules
0605010I0BBABAB
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 300units/0.48ml inj pre-filled pens
0605010I0BBANAU
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 300units/0.5ml inj pre-filled syringes
0605010I0BBAHAH
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 37.5unit inj ampoules
0605010I0BBACAC
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450unit inj vials
0605010I0BBAGAG
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450units/0.72ml inj pre-filled pens
0605010I0BBAPAV
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 450units/0.75ml inj pre-filled syringes
0605010I0BBAIAI
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 75unit inj ampoules
0605010I0BBAAAA
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 75unit inj vials
0605010I0BBAEAE
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonal-f 900units/1.5ml inj pre-filled syringes
0605010I0BBAJAJ
|
Gonal-F | Follitropin alfa | Endocrine System | No data available |
|
Gonasi HP 2,000unit inj vials
0605010D0BFAAAH
|
Gonasi HP | Chorionic gonadotrophin | Endocrine System | No data available |
|
Gopten 1mg capsules
0205051U0BBABAB
|
Gopten | Trandolapril | Cardiovascular System | No data available |
|
Gopten 2mg capsules
0205051U0BBACAC
|
Gopten | Trandolapril | Cardiovascular System | No data available |
|
Gopten 4mg capsules
0205051U0BBADAF
|
Gopten | Trandolapril | Cardiovascular System | No data available |
|
Gopten 500microgram capsules
0205051U0BBAAAA
|
Gopten | Trandolapril | Cardiovascular System | No data available |
|
Gosa-S 500mg capsules
091200000BFRHDJ
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Gosa-S 500mg tablets
091200000BFRGDG
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Gosa-S 750mg tablets
091200000BFRIDI
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Gosachew 1500mg chewable tablets
1001050A0BTAAAC
|
Gosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Gosachew 500mg/400mg chewable tablets
1001050A0BTABAD
|
Gosachew | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Gosaveg 750mg tablets
1001050A0BYAAAB
|
Gosaveg | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | No data available |
|
Gramicidin/Neomycin/Nystatin/Triamcinolone acetonide oint
1304000Z0AACJCJ
|
Triamcinolone acetonide (Topical) | Triamcinolone acetonide | Skin | No data available |
|
Graneodin ointment
1310011P0BCAAAJ
|
Graneodin (Topical) | Neomycin sulfate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.